Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer
2025

Identifying New Protein Interactions in Triple-Negative Breast Cancer

Sample size: 114 publication 10 minutes Evidence: high

Author Information

Author(s): LI XIANG, JIN WENKE, WU LIFENG, WANG HUAN, XIE XIN, HUANG WEI, LIU BO

Primary Institution: Chengdu University of Traditional Chinese Medicine and Sichuan University

Hypothesis

Can deep learning uncover novel protein-protein interactions related to autophagy in triple-negative breast cancer?

Conclusion

The study identifies the Beclin 2-Ubiquilin 1 axis as a promising target for precision therapy in triple-negative breast cancer.

Supporting Evidence

  • 3733 previously unknown autophagy-related protein-protein interactions were identified.
  • Beclin 2 was found to interact with 39 newly identified proteins.
  • Overexpression of Beclin 2 increased Ubiquilin 1 levels and promoted autophagy-dependent cell death.

Takeaway

Researchers used computers to find new ways proteins interact in a type of breast cancer, which could help create better treatments.

Methodology

The study employed machine learning algorithms to analyze protein-protein interactions and validated findings through experimental methods including immunoprecipitation and mass spectrometry.

Limitations

The applicability of findings to other TNBC cell lines or in vivo models requires further investigation.

Participant Demographics

114 TNBC samples and 99 normal control samples were analyzed.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.32604/or.2024.055921

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication